Gregor received the opportunity to present a poster on our preliminary study findings at the Society of Urologic Oncology's 21st annual scientific meeting. The meeting was held on December 3-5, 2020. The Society of Urologic Oncology sponsors this highly interactive meeting where attendees participate in discussions led by internationally renowned urologic oncologists, medical oncologists, and scientists. State-of-the-art translational topics on prostate, kidney, and bladder cancer, as well as strategies in urologic oncology were discussed.
Gregor completed a preliminary study in Spring of 2020. The study collected seminal fluid samples from men 50+ across the US at 14 sites. The samples were analyzed to screen for prostate cancer. The poster highlights the test's sensitivity and specificity, 79% and 88% respectively. The Gregor Test uses seminal fluid to test a broad range of biomarkers that allows the test to provide a better alternative to the current screening methodology, Prostate Specific Antigen (PSA). A full version of the poster can be viewed here.